Oracle Health and Epic are looking at the electronic health records market in countries where the digitization of healthcare ...

KeyBanc raised the firm’s price target on Oracle (ORCL) to $200 from $190 and keeps an Overweight rating on the shares. Oracle has seen ...

In a report released today, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx (OPRX – Research Report), with a ...